- Holter monitoring at baseline which demonstrates a total of 15 minutes of ischemia
and/or 3 ischemic events per 48 hours.
- Total cholesterol > 5.2 mmol/L (200 mg/dL) on diet alone.
- Myocardial infarction within 2 months prior to the study.
- Likelihood of requiring treatment during the study period with drugs not permitted by
the study protocol.